Literature DB >> 4400571

Role of adrenergic neurone blockade in the hypotensive action of propranolol.

S Eliash, M Weinstock.   

Abstract

1. Propranolol, in doses of 25-100 mug/kg, blocks contractions of the nictitating membrane to nerve stimulation but not to injected noradrenaline.2. This adrenergic neurone blocking action of propranolol is antagonized by amphetamine.3. It is also reversed by raising the dose of propranolol to amounts exceeding 0.5 mg/kg.4. Still larger amounts potentiate the responses of the nictitating membrane to both submaximal stimulation of the cervical sympathetic nerve and to injected noradrenaline.5. The (+) isomer of propranolol produced adrenergic nerve blockade and some degree of hypotension without blocking cardiac beta-adrenoceptors.6. The relevance of adrenergic neurone blockade to the hypotensive effect of propranolol is discussed.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4400571      PMCID: PMC1665837     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Prejunctional actions of some beta-adrenoreceptor antagonists in the vas deferens preparation of the guinea-pig.

Authors:  E J Mylecharane; C Raper
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

2.  Sympathetic involvement in vagal escape and the effects of beta-receptor blocking drugs.

Authors:  C Raper; J Wale
Journal:  Eur J Pharmacol       Date:  1969-10       Impact factor: 4.432

3.  An adrenergic neuron blocking action of propranolol in isolated tissues.

Authors:  M D Day; D A Owen; P R Warren
Journal:  J Pharm Pharmacol       Date:  1968-12       Impact factor: 3.765

4.  The paradox of beta-adrenergic blockade in hypertension.

Authors:  E D Frohlich; R C Tarazi; H P Dustan; I H Page
Journal:  Circulation       Date:  1968-03       Impact factor: 29.690

5.  Evaluation of the hypotensive effect of beta-adrenergic blockade in hypertension.

Authors:  S Dorph; C Binder
Journal:  Acta Med Scand       Date:  1969-05

6.  Adrenergic neuron blocking properties of (plus or minus)-propranolol and (plus)-propranolol.

Authors:  A M Barrett; B Nunn
Journal:  J Pharm Pharmacol       Date:  1970-11       Impact factor: 3.765

7.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04

8.  A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals.

Authors:  J B Farmer; G P Levy
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

9.  The effects of some beta-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart.

Authors:  J W Foo; A Jowett; A Stafford
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

10.  Controlled trial of propranolol in hypertension.

Authors:  F J Zacharias; K J Cowen
Journal:  Br Med J       Date:  1970-02-21
View more
  14 in total

1.  Effects of beta-adrenoreceptor blocking drugs on adrenergic transmission.

Authors:  M Rand; M Law; D F Story; M W McCulloch
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Possible role of a beta-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism.

Authors:  E Adler-Graschinsky; S Z Langer
Journal:  Br J Pharmacol       Date:  1975-01       Impact factor: 8.739

3.  Stimulation of presynaptic beta-adrenoceptors enhances [3H]-noradrenaline release druing nerve stimulation in the perfused cat spleen.

Authors:  S M Celuch; M L Dubocovich; S Z Lander
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

4.  The uptake and overflow of radiolabelled beta-adrenoceptor blocking agents by the isolated vas deferens of the rat.

Authors:  M J Lewis
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

5.  Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.

Authors:  B G Hansson; J F Dymling; P Manhem; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

6.  Effect of propranolol on the blood pressure of normotensive and pinealectomized hypertensive rats.

Authors:  H Karppanen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  The influence of propranolol on abnormal behaviour induced in rats by prolonged isolation--an animal model for mania?

Authors:  Z Speizer; M Weinstock
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

8.  Factors influencing the adrenergic neurone blocking action of propranolol.

Authors:  S Eliash; M Weinstock
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

9.  R-enantiomer of timolol: a potential selective ocular antihypertensive agent.

Authors:  N N Share; V J Lotti; P Gautheron; C Schmitt; D M Gross; R A Hall; C A Stone
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

10.  The effect of propranolol on vascular responses to sympathetic nerve stimulation.

Authors:  P M Dawes; D C Faulkner
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.